One in Two

In this special episode, we speak to Dr Jen Davies-Oliveira, a researcher and PhD student at The University of Manchester and Stewart O’Callaghan, the Founder and Chief Executive of Live Through This, the UK’s only LGBTQIA+ Cancer charity. We discuss challenges that LGBTQIA+ people face when accessing cancer care in the UK, Jen’s research project in alternative cervical screening which aims to tackle some of these inequalities and Stewart’s experiences as a person living with cancer, how they came to set up their charity and how it is aligned with research.     Live through this: https://livethroughthis.co.uk/   Jo’s Cervical Cancer Trust: https://www.jostrust.org.uk/   Answer cancer GM: https://www.answercancergm.org.uk/   LGBT foundation: https://lgbt.foundation/   Peaches Womb Cancer Trust: https://peachestrust.org/ 

Show Notes

 In this special episode, we speak to Dr Jen Davies-Oliveira, a researcher and PhD student at The University of Manchester and Stewart O’Callaghan, the Founder and Chief Executive of Live Through This, the UK’s only LGBTQIA+ Cancer charity. We discuss challenges that LGBTQIA+ people face when accessing cancer care in the UK, Jen’s research project in alternative cervical screening which aims to tackle some of these inequalities and Stewart’s experiences as a person living with cancer, how they came to set up their charity and how it is aligned with research. 
  
 Live through this: https://livethroughthis.co.uk/
  
 Jo’s Cervical Cancer Trust: https://www.jostrust.org.uk/
  
 Answer cancer GM: https://www.answercancergm.org.uk/
  
 LGBT foundation: https://lgbt.foundation/
  
 Peaches Womb Cancer Trust: https://peachestrust.org/ 

What is One in Two?

With one in two of us receiving a cancer diagnosis at some point during our lives, it has never been more important to improve the outcomes for people affected by cancer.

This cancer research podcast is brought to you by The University of Manchester in partnership with the Manchester Cancer Research Centre (MCRC). In each episode, our cancer researchers discuss the innovations, discoveries and projects that are changing the landscape of early detection.